CLINICAL_TRIALS
research
· 2024-06-21
Clinical Trial Update: F01 in the Treatment of Moderate-to-severe Refractory Systemic Lupus Erythematosus [Phase 1]
Summary
Phase 1 clinical trial update for F01 in moderate-to-severe refractory systemic lupus erythematosus; the study is not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shanghai Simnova Biotechnology Co.,Ltd. | Conditions: Lupus Erythematosis | Phase 1 | Status: NOT_YET_RECRUITING